Frontage HoldingsFGHQF -3.57%58 EV-to-FCF is 10.47 as of Jul. 06, 2026, which is 72% below its 10-year median of 37.99. GuruFocus rates FGHQF with a GF Score™ of 58/100 and a GF Value™ of $0.21 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 331 Biotechnology companies, Frontage Holdings ranks better than 58.01% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Frontage Holdings's Enterprise Value is $338.0 Mil.
Frontage Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $32.3 Mil. Therefore, Frontage Holdings's EV-to-FCF for today is 10.47.
The historical rank and industry rank for Frontage Holdings's EV-to-FCF or its related term are showing as below:
FGHQF'
s EV-to-FCF Range Over the Past 10 Years
Min: -171.12 Med: 37.99 Max: 216.36
Current: 10.67
During the past 10 years, the highest EV-to-FCF of Frontage Holdings was 216.36. The lowest was -171.12. And the median was 37.99.
FGHQF's EV-to-FCF is ranked better than 58.01% of 331
companies
in the Biotechnology industry
Industry Median: 16.48
vs FGHQF: 10.67
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Frontage Holdings's PE Ratio (TTM) for today is calculated as:
Frontage Holdings's share price for today is $0.135.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Frontage Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Frontage Holdings EV-to-FCF Related Terms
Frontage Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Frontage Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Frontage Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontage Holdings EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Frontage Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Frontage Holdings's EV-to-FCF falls into.
Frontage Holdings's current Enterprise Value is $338.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Frontage Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $32.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frontage Holdings (FGHQF) has a EV-to-FCF of 10.47 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Frontage Holdings and its competitors. This is 72% below median its historical median of 37.99. According to the industry distribution chart, Frontage Holdings ranks #139 out of 331 companies in the Biotechnology industry, placing it in the top 42%.
Is Frontage Holdings' EV-to-FCF too high?
Frontage Holdings' current EV-to-FCF of 10.47 is 72% below median its 10-year median of 37.99. The Biotechnology industry median EV-to-FCF is 16.48. Frontage Holdings' value of 10.47 is 36.5% below this industry median. Based on the distribution chart, Frontage Holdings ranks #139 out of 331 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Frontage Holdings has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Frontage Holdings' EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Frontage Holdings ranks #139 out of 331 companies for EV-to-FCF. This puts Frontage Holdings in the upper half of its industry. The industry median EV-to-FCF is 16.48. Frontage Holdings' value of 10.47 is 36.5% below this benchmark. While the company's 10-year median is 37.99 vs. the industry median of 16.48, Frontage Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.48, based on 331 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frontage Holdings's current EV-to-FCF of 10.47 is 36.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Frontage Holdings and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frontage Holdings's current EV-to-FCF is 10.47, which is 72% below median its own 10-year median of 37.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontage Holdings stock overvalued right now?
Based on GuruFocus' analysis, Frontage Holdings (FGHQF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.14 — trading 35.7% below its estimated fair value. The current EV-to-FCF is 10.47, which is 72% below median its 10-year median of 37.99 and 36.5% below the Biotechnology industry median of 16.48. Frontage Holdings' overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Frontage Holdings (FGHQF), the current EV-to-FCF is 10.47 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frontage Holdings (FGHQF) Overvalued in 2026?
Based on GuruFocus' analysis, Frontage Holdings stock appears to be undervalued.
The current stock price of $0.14 is trading 35.7% below its estimated GF Value™ of $0.21.
GuruFocus considers Frontage Holdings to be Possible Value Trap.
Key valuation signals for FGHQF:
EV-to-FCF: 10.47 (72% below median its 10-year median of 37.99)
GF Value™: $0.21 vs. price of $0.14 (35.7% below fair value)
Industry Position: 36.5% below the Biotechnology median (#139 of 331)
No single metric tells the full story. See the FGHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
58GF Score
Get the complete analysis for FGHQF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FGHQF has been successfully added to your 
